Freeze-dried Live Attenuated Measles, Rubella Combined Vaccine (Mitsubishi Tanabe)

冻干麻疹、风疹减毒减毒活联合疫苗(田边三菱)

Report date: 2026/01/20 09:54:02

Base Information

Drug NameFreeze-dried Live Attenuated Measles, Rubella Combined Vaccine (Mitsubishi Tanabe)
Drug Alias NameMearubik II
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMeasles
Global Approved IndicationsRubellaMeasles
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2025/01/24
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRubellaMeasles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A